Results 71 to 80 of about 39,211 (299)

Advances in Pharmacogenomics

open access: yes, 2021
<p> <span style="color:#202122;">Pharmacogenomics is the study of the role of the genome in drug response. Its name (pharmaco- + genomics) reflects its combining of pharmacology and genomics.
Gillian Bartlett   +4 more
core   +1 more source

The impact of pharmacogenetic‐informed care on medication adherence and psychological factors associated with adherence: A narrative review

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Improvement in medication adherence is often proposed as a potential advantage of pharmacogenetic‐guided prescribing over a traditional one‐size‐fits‐all approach. This paper provides a review of the published literature and presents the findings of studies that measure adherence to medication as an outcome of pharmacogenetic‐informed care, or that ...
Lucy Galloway   +2 more
wiley   +1 more source

Precision medicine in pharmacy: assessing pharmacogenomics competence among pharmacists and pharmacy students

open access: yesJournal of Pharmaceutical Policy and Practice
Background Pharmacogenomics, a key component of precision medicine, aims to improve healthcare outcomes. As pharmacists play a pivotal role in this evolving field, an assessment of their preparedness to apply pharmacogenomics is imperative.Methods In ...
Mohanad Odeh   +4 more
doaj   +1 more source

Clinical Knowledge, Attitude, and Perceptions of Community Pharmacists Towards Pharmacogenomics - A Cross-Sectional Study from Saudi Arabia

open access: yesPharmacogenomics and Personalized Medicine, 2023
Ziyad Alrabiah, Wajid Syed, Salmeen D Babelghaith, Mohamed N Al Arifi Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi ArabiaCorrespondence: Wajid Syed, Email wali@ksu.edu.saBackground and Aims: It is ...
Alrabiah Z   +3 more
doaj  

Pharmacogenomics in epilepsy

open access: yesNeuroscience Letters, 2018
There is high variability in the response to antiepileptic treatment across people with epilepsy. Genetic factors significantly contribute to such variability. Recent advances in the genetics and neurobiology of the epilepsies are establishing the basis for a new era in the treatment of epilepsy, focused on each individual and their specific epilepsy ...
Balestrini S, Sisodiya SM
openaire   +4 more sources

Dual‐Plane Engineered GO‐Shielded GaN Core–Shell Nanowires for Cl−‐Resilient and Durable Seawater Splitting Photoelectrodes

open access: yesCarbon Energy, EarlyView.
The double‐bond phenomenon enables dual energy band mechanisms that enhance the efficiency of seawater splitting. Atomic interactions at the GO/GaN interface encompass various configurations, such as van der Waals interactions, covalent interactions, type‐II and Z‐scheme alignments, and chloride‐ion repulsion.
Bagavath Chandran   +7 more
wiley   +1 more source

Age-Related Variations in Clinical and Biochemical Profiles of People Living With HIV

open access: yesAIDS Research and Treatment
People living with HIV (PLHIV) are at increased risk of liver and kidney dysfunction due to chronic HIV infection, long-term antiretroviral therapy (ART), and persistent immune activation.
Oksana Ryabinina   +6 more
doaj   +1 more source

Expanding Pharmacist and Student Pharmacist Access to Genetics/Genomics/Pharmacogenomics Competency Education

open access: yesJournal of Medical Education and Curricular Development, 2019
Background: As pharmacogenomics (PGx), a component of genetics/genomics and precision medicine, gains traction in the clinical setting, education of health care providers and health professions students must be made broadly available to improve ...
David F Kisor, Christopher L Farrell
doaj   +1 more source

Cancer Pharmacogenomics

open access: yes, 2011
Pharmacogenomics research is yielding molecular diagnostic tools that can be used to optimize the selection of medications and their doses for individual patients.
W. E. Evans   +11 more
core   +1 more source

Genomic Insights Into Risperidone Treatment Outcomes in Children and Adolescents: Experience From a Psychiatric Hospital Serving Rural Youth

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Risperidone is a commonly used antipsychotic for treating psychiatric illness in children and adolescents. There is a large variability in risperidone response and discontinuation rates remain high. Pharmacogenomics offers the opportunity to improve risperidone outcomes, yet studies in pediatric populations are limited.
Jack W. Staples   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy